Treatment of Uterine Bleeding During Chemotherapy

作者: Nicole Sänger , Michael von Wolff , Frank Nawroth

DOI: 10.1007/978-3-030-47568-0_28

关键词:

摘要: The administration of gonadotoxic agents (e.g. during chemotherapy) in premenopausal women can lead to vaginal bleeding disorders and pose a difficult treatment situation for oncological specialists. This chapter describes practical options serious events by considering hormonal non-hormonal drugs (such as e.g. oral contraceptives, GnRH agonists, tranexamic acid). A distinction is made between prevention bleedings acute bleeding, stating possible medications, medical combinations dosages. Radiological or surgical interventional procedures are also discussed, although they rarely used.

参考文章(15)
Melissa Merideth, Christa Zerbe, Jennifer Cuellar-Rodriguez, Dana Shanis, Pamela Stratton, Stephanie E Purisch, Management of uterine bleeding during hematopoietic stem cell transplantation. Obstetrics & Gynecology. ,vol. 121, pp. 424- 427 ,(2013) , 10.1097/AOG.0B013E318270ECD3
C. Lhommé, PH. Brault, J. H. Bourhis, P. Pautier, N. Dohollou, P. Y. Dietrich, G. Akbar-Zadeh, C. Lucas, J. L. Pico, M. Hayat, Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study. Leukemia & Lymphoma. ,vol. 42, pp. 1033- 1041 ,(2001) , 10.3109/10428190109097723
S. Sica, P. Salutari, A. Di Mario, P. Chiusolo, S. Rutella, E. Ortu La Barbera, G. Leone, P. Scirpa, Treatment and prophylaxis of hypermenorrhea with leuprorelin in premenopausal women affected by acute leukemia at diagnosis American Journal of Hematology. ,vol. 51, pp. 248- 249 ,(1996) , 10.1002/(SICI)1096-8652(199603)51:3<248::AID-AJH17>3.0.CO;2-C
Jill S Bates, Larry W Buie, C. Brock Woodis, Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy. Pharmacotherapy. ,vol. 31, pp. 1092- 1110 ,(2011) , 10.1592/PHCO.31.11.1092
Andrea S. Lukes, Ken Muse, Holly E. Richter, Keith A. Moore, Donald L. Patrick, Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding. Current Medical Research and Opinion. ,vol. 26, pp. 2673- 2678 ,(2010) , 10.1185/03007995.2010.526098
P Chiusolo, P Salutari, S Sica, P Scirpa, L Laurenti, N Piccirillo, G Leone, Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation Bone Marrow Transplantation. ,vol. 21, pp. 821- 823 ,(1998) , 10.1038/SJ.BMT.1701187
Jacques Donnez, Tetyana F Tatarchuk, Philippe Bouchard, Lucian Puscasiu, Nataliya F Zakharenko, Tatiana Ivanova, Gyula Ugocsai, Michal Mara, Manju P Jilla, Elke Bestel, Paul Terrill, Ian Osterloh, Ernest Loumaye, None, Ulipristal acetate versus placebo for fibroid treatment before surgery. The New England Journal of Medicine. ,vol. 366, pp. 409- 420 ,(2012) , 10.1056/NEJMOA1103182
A. Altes, S. Brunet, J. Calaf, E. Capdevila, J. Nomdeoeu, A. Sureda, Richard Ghalie, Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. American Journal of Hematology. ,vol. 42, pp. 350- 353 ,(1993) , 10.1002/AJH.2830460116